Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics

Background and purpose: Radiotherapy centers frequently lack simple tools for periodic treatment plan verification and feedback on current plan quality. It is difficult to measure treatment quality over different years or during the planning process. Here, we implemented plan quality assurance (QA)...

Full description

Bibliographic Details
Main Authors: Ana Vaniqui, Richard Canters, Femke Vaassen, Colien Hazelaar, Indra Lubken, Kirsten Kremer, Cecile Wolfs, Wouter van Elmpt
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Physics and Imaging in Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405631620300695
id doaj-e36614ba42dc44f582a3b0d8a4fa3bd4
record_format Article
spelling doaj-e36614ba42dc44f582a3b0d8a4fa3bd42020-12-19T05:09:23ZengElsevierPhysics and Imaging in Radiation Oncology2405-63162020-10-01167480Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metricsAna Vaniqui0Richard Canters1Femke Vaassen2Colien Hazelaar3Indra Lubken4Kirsten Kremer5Cecile Wolfs6Wouter van Elmpt7Corresponding author.; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsDepartment of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the NetherlandsBackground and purpose: Radiotherapy centers frequently lack simple tools for periodic treatment plan verification and feedback on current plan quality. It is difficult to measure treatment quality over different years or during the planning process. Here, we implemented plan quality assurance (QA) by developing a database of dose-volume histogram (DVH) metrics and a prediction model. These tools were used to assess automatically optimized treatment plans for rectal cancer patients, based on cohort analysis. Material and methods: A treatment plan QA framework was established and an overlap volume histogram based model was used to predict DVH parameters for cohorts of patients treated in 2018 and 2019 and grouped according to planning technique. A training cohort of 22 re-optimized treatment plans was used to make the prediction model. The prediction model was validated on 95 automatically generated treatment plans (automatically optimized cohort) and 93 manually optimized plans (manually optimized cohort). Results: For the manually optimized cohort, on average the prediction deviated less than 0.3 ± 1.4 Gy and −4.3 ± 5.5 Gy, for the mean doses to the bowel bag and bladder, respectively; for the automatically optimized cohort a smaller deviation was observed: −0.1 ± 1.1 Gy and −0.2 ± 2.5 Gy, respectively. The interquartile range of DVH parameters was on average smaller for the automatically optimized cohort, indicating less variation within each parameter compared to manual planning. Conclusion: An automated framework to monitor treatment quality with a DVH prediction model was successfully implemented clinically and revealed less variation in DVH parameters for automated in comparison to manually optimized plans. The framework also allowed for individual feedback and DVH estimation.http://www.sciencedirect.com/science/article/pii/S2405631620300695Treatment planning QAPrediction modelOverlap volume histogram (OVH)Knowledge based treatment planningDose–distance relation
collection DOAJ
language English
format Article
sources DOAJ
author Ana Vaniqui
Richard Canters
Femke Vaassen
Colien Hazelaar
Indra Lubken
Kirsten Kremer
Cecile Wolfs
Wouter van Elmpt
spellingShingle Ana Vaniqui
Richard Canters
Femke Vaassen
Colien Hazelaar
Indra Lubken
Kirsten Kremer
Cecile Wolfs
Wouter van Elmpt
Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics
Physics and Imaging in Radiation Oncology
Treatment planning QA
Prediction model
Overlap volume histogram (OVH)
Knowledge based treatment planning
Dose–distance relation
author_facet Ana Vaniqui
Richard Canters
Femke Vaassen
Colien Hazelaar
Indra Lubken
Kirsten Kremer
Cecile Wolfs
Wouter van Elmpt
author_sort Ana Vaniqui
title Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics
title_short Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics
title_full Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics
title_fullStr Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics
title_full_unstemmed Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics
title_sort treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics
publisher Elsevier
series Physics and Imaging in Radiation Oncology
issn 2405-6316
publishDate 2020-10-01
description Background and purpose: Radiotherapy centers frequently lack simple tools for periodic treatment plan verification and feedback on current plan quality. It is difficult to measure treatment quality over different years or during the planning process. Here, we implemented plan quality assurance (QA) by developing a database of dose-volume histogram (DVH) metrics and a prediction model. These tools were used to assess automatically optimized treatment plans for rectal cancer patients, based on cohort analysis. Material and methods: A treatment plan QA framework was established and an overlap volume histogram based model was used to predict DVH parameters for cohorts of patients treated in 2018 and 2019 and grouped according to planning technique. A training cohort of 22 re-optimized treatment plans was used to make the prediction model. The prediction model was validated on 95 automatically generated treatment plans (automatically optimized cohort) and 93 manually optimized plans (manually optimized cohort). Results: For the manually optimized cohort, on average the prediction deviated less than 0.3 ± 1.4 Gy and −4.3 ± 5.5 Gy, for the mean doses to the bowel bag and bladder, respectively; for the automatically optimized cohort a smaller deviation was observed: −0.1 ± 1.1 Gy and −0.2 ± 2.5 Gy, respectively. The interquartile range of DVH parameters was on average smaller for the automatically optimized cohort, indicating less variation within each parameter compared to manual planning. Conclusion: An automated framework to monitor treatment quality with a DVH prediction model was successfully implemented clinically and revealed less variation in DVH parameters for automated in comparison to manually optimized plans. The framework also allowed for individual feedback and DVH estimation.
topic Treatment planning QA
Prediction model
Overlap volume histogram (OVH)
Knowledge based treatment planning
Dose–distance relation
url http://www.sciencedirect.com/science/article/pii/S2405631620300695
work_keys_str_mv AT anavaniqui treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
AT richardcanters treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
AT femkevaassen treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
AT colienhazelaar treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
AT indralubken treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
AT kirstenkremer treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
AT cecilewolfs treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
AT woutervanelmpt treatmentplanqualityassessmentforradiotherapyofrectalcancerpatientsusingpredictionoforganatriskdosemetrics
_version_ 1724377698970632192